How does the Bdparib 300 mg tablet work?

Bdparib 300mg tablet inhibits the enzyme that plays an important role in DNA repair by inhibiting poly-adenosine diphosphate-ribose polymerase enzymes such as PARP-1, PARP-2, and PARP-3, which play a role in DNA repair. By blocking an enzyme associated with DNA repair, the spread of cancer cells can be stopped, resulting in their death. Bdparib 300mg tablet does not allow damaged DNA to get repaired.

What information should be told to the doctor before taking a Bdparib 300 mg tablet?

Inform the doctor if you are allergic to the ingredient present in the Bdparib 300 mg tablet, in case of high sugar level, pregnancy or breastfeeding, or a weakened immune system. A patient with a medical history or medication must discuss it with a doctor.

Can I drink alcohol while taking the Bdparib 300 mg tablet?

It is advised not to take alcohol while taking the Bdparib 300 mg tablet, because consuming alcohol can cause serious side effects and can damage your liver badly. Consult your doctor if you have concerns or queries.

What are the side effects of the Bdparib 300 mg tablet?

Common side effects of the Bderlo 150 mg Tablet are constipation, muscle pain, swelling, nausea, diarrhea, infection, loss of appetite, hair loss, vomiting, and weakness.

I forgot to take the Bdparib 300 mg tablet. What to do?

As soon as you remember, take the missed dose unless it's time for your next dose. You should never take a double dose to make up for a missed one.

Is it safe to take this Bdparib 300 mg tablet during pregnancy or breastfeeding?

During pregnancy, it is not safe to take the Bdparib 300mg tablet, as it can cause harm to the unborn baby. Furthermore, during breastfeeding, this medicine must not be used. Please make sure to consult your healthcare provider regarding the same.

Deal of the Day — limited-time pharmacy picks!Deal of the Day — today's spotlight pharmacy prices, refreshed daily.

Bdparib 300mg Tablet

Name: Bdparib 300mg Tablet
Brand: Bdparib
Price: 40300 INR
Availability: InStock
Rating: 4.71 (7 reviews)

Rx Required

Salt Composition: Rucaparib

Expiry Date: 01/2028

Price on Request

Inclusive of all taxes

▼

60 Tablet in Bottle

About The Product

Ovarian Cancer, Prostate cancer

Bdparib 300mg tablet belongs to the class called polyADP-ribose polymerase inhibitors. It is an anti-cancer medicine, containing the active ingredient rucaparib. It is used for the treatment of primary peritoneal cancer (a layer of tissue that lines the abdomen), fallopian tube (present in females), and certain types of ovarian cancer. Bdparib 300mg tablet is also used to treat certain types of cancer in people with a specific gene (BRCA) change. This cancer medicine should be taken by individuals who are allergic to Bdparib or any of the ingredients.

Uses

Prostate cancer, Fallopian tube cancer, Ovarian cancer, primary peritoneal cancer.

Side Effects

Undesired symptoms or responses vary from person to person as the human body reacts differently to the Bdparib 300 mg tablet.
Still, they typically resolve naturally within a few days as the body adjusts to the medicine, requiring no medical attention.
In case these symptoms don't go away and you face severe side effects, then immediately consult your doctor or medical team.
Some of the common side effects of the Bdparib 300 mg tablet are: Headache, Fever Loss of appetite Pain in the eyes Blurred vision High blood pressure Dry skin lack of sleep.
Vomiting Indigestion Nausea Reduced Kidney function, diarrhea, or constipation

How To Use

Bdparib 300mg tablet is not a drug used for self-medication; it should always be taken as directed by a physician.
As advised by the physician, it can be taken either with or without food.
Your doctor will decide the dose and timing of the Bdparib 300 mg based on the disease condition and other factors.
For best results in its effectiveness, the Bdparib 300mg tablet must be swallowed rather than chewed, opened, or crushed.
It is an oral drug that is given once daily, before meals, at the same time every day.
The Bdparib 300mg tablet should not be taken for at least three hours before or after food.
Take it as prescribed by the physician.

Safety Advice

Alcohol

Drinking too much alcohol could damage a person's immunity and liver function. Alcohol consumption can cause dizziness, confusion, tiredness, and cognitive impairment, so it is advised not to consume alcohol while taking the Bdparib 300mg tablet.

Pregnancy

It is not advised to take the Bdparib 300mg tablet when pregnant because it affects the fetus. This is not for use in pregnant women.

Breast Feeding

Because there is a possibility that the Bdparib 300mg tablet could be transferred to the developing infant through the mother's breast milk, it is not advised to consume it while nursing. It is widely regarded as dangerous, and there is not enough evidence in the clinical data on its adverse impacts on infants.

Driving

Taking a BDPARIB 300mg tablet while operating machinery may cause confusion or affect one's capacity to drive. The capsule may cause neurological side effects, such as fever or feeling dizzy. Until you feel better, don't drive.

Kidney

People with kidney issues can use the Bdparib 300mg tablet after consulting with the doctor. It may harm the kidneys if taken as self-medication

Liver

People with severe liver illness should not use the Bdparib 300mg tablet. Whereas people with mild liver disease can use this solution, but it must be regularly monitored. Use caution and alter the dosage of the Bdparib 300mg tablet as advised by your doctor.

FAQs

The doctor decides how long the treatment with the Bdparib 300mg tablet will continue, depending on the stage and health of the patient.

Reference

Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W.

W., Comber, H., & Bray, F. (2023).

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. European journal of cancer, 49(6), 1374-1403.

Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., & Oza, A.

(2021). Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.

The Lancet Oncology, 12(9), 852-861. Guo, X.

X., Wu, H. L., Shi, H.

Y., Su, L., & Zhang, X. (2025).

The efficacy and safety of olaparib in the treatment of cancers: a meta-analysis of randomized controlled trials. Cancer Management and Research, 2553-2562.

Pujade-Lauraine, E., Ledermann, J. A., Selle, F., Gebski, V., Penson, R.

T., Oza, A. M., & Vergote, I.

(2025). Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.

The Lancet Oncology, 18(9), 1274-1284. Zhou, D., Li, J., Learoyd, M., Bui, K., Berges, A., Milenkova, T., & Xu, H.

(2024). Efficacy and safety exposure‐response analyses of olaparib capsule and tablet formulations in oncology patients.

Clinical Pharmacology & Therapeutics, 105(6), 1492-1500.

Certified Content

Written By

Venika Choudhary

Medical Content Writer @ Magicine Pharma

Reviewed By

Dr. Aditya Sarin

MBBS, MD - General Medicine, DrNB - Medical Oncology | 11 Years Experience

Check Our Editorial Policy

Last updated: 14 Sept 2026 | 04:41 PM (IST)

Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only

Not a substitute for professional medical advice

Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.

Read full medical disclaimer in Terms & Conditions